1. Sasahira, Tomonori, Bosserhoff, Anja Katrin, Kirita, Tadaaki. 2018. The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer. In Pathology international, 68, 278-286. doi:10.1111/pin.12672. https://pubmed.ncbi.nlm.nih.gov/29655307/
2. Robertson, N G, Heller, S, Lin, J S, Hudspeth, A J, Morton, C C. . A novel conserved cochlear gene, OTOR: identification, expression analysis, and chromosomal mapping. In Genomics, 66, 242-8. doi:. https://pubmed.ncbi.nlm.nih.gov/10873378/
3. Wang, Yu-Fei, Han, Jie. 2019. OTOR in breast carcinoma as a potent prognostic predictor correlates with cell proliferation, migration, and invasiveness. In Biochemistry and cell biology = Biochimie et biologie cellulaire, 97, 750-757. doi:10.1139/bcb-2018-0305. https://pubmed.ncbi.nlm.nih.gov/30897334/
4. Man, Jing, Zhou, Wanbiao, Zuo, Shi, Ma, Huaxing, Li, Hai-Yang. 2023. TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway. In Biochemical pharmacology, 213, 115615. doi:10.1016/j.bcp.2023.115615. https://pubmed.ncbi.nlm.nih.gov/37211171/
5. Bisht, Shilpa, Chawla, Bhavna, Kumar, Amit, Sharma, Pradeep, Dada, Rima. 2022. Identification of novel genes by targeted exome sequencing in Retinoblastoma. In Ophthalmic genetics, 43, 771-788. doi:10.1080/13816810.2022.2106497. https://pubmed.ncbi.nlm.nih.gov/35930312/